Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)

Why established systems and relationships matter

HLA matching could bring more allogeneic cell therapies to market, faster

An expert opinion on HLA matching relevance for allogeneic cell therapies

Advancements in Cell and Gene Therapy: 2019 Year-in-Review

Cell collection standards for cell therapies

A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies

Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

Advancements in Cell Therapy: 2018 Year-In-Review

Reimbursement uncertainties hinder patient access to CAR-T therapies

Be The Match BioTherapies and Cryoport Launch Strategic Partnership

Organization announces collaboration that will deliver end-to-end supply chain services to the cell and gene therapy industry